Intelligence · Clinical Pipeline
Approved programs Pipeline Programs
ClinicalTrials.gov programs marked approved or launched in registry data.
- Programs
- 1,839
Quick answer
NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.
Top sponsors
- Chinese Academy of 207 programs
- First People's Hospital 186 programs
- Takeda 154 programs
- United Therapeutics Europe 121 programs
- BRIGHT MINDS BIOSCIENCES 116 programs
- Disc Medicine 103 programs
- George Institute for 83 programs
- Hospital Authority 60 programs
- Regeneron UK 60 programs
- Sinovac Research and 47 programs
- Teva Pharma 39 programs
- Pacira Ireland 36 programs
-
Vancomycin
United Therapeutics Europe Ltd
Open Fracture
1 trial -
Vancomycin
The First People's Hospital of Lianyungang
Blood Stream Infections
1 trial -
Vardenafil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Erectile Dysfunction
1 trial -
Varenicline
BRIGHT MINDS BIOSCIENCES INC.
Parkinson's Disease
1 trial -
Varenicline
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
2 trials -
Varenicline
BRIGHT MINDS BIOSCIENCES INC.
Smoking Cessation
3 trials -
Varenicline
BRIGHT MINDS BIOSCIENCES INC.
Vaping
1 trial -
Varicella vaccine
Sinovac Research and Development Co.,
VZV
1 trial -
Varicella vaccine+TIV
Sinovac Research and Development Co.,
Varicella
1 trial -
Vaxigrip Tetra, suspensie voor injectie in een voorgevulde spuit Quadrivalent griepvaccin (gesplitst virion, geïnactiveerd), Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)
Disc Medicine
healthy individuals
1 trial -
Vedolizumab
Second Affiliated Hospital of Soochow University
Ulcerative Colitis (UC)
1 trial -
Vedolizumab
Takeda
Moderately to Severely Active Crohn's Disease
1 trial -
Vedolizumab
Takeda
Crohn's Disease
6 trials -
Vedolizumab
Takeda
Crohn Disease
4 trials -
Vedolizumab 300 mg
Takeda
Colitis, Ulcerative
1 trial -
Vedolizumab IV
Takeda
Colitis, Ulcerative
1 trial -
Vedolizumab Placebo
Takeda
Pouchitis
1 trial -
Velaglucerase Alfa
Takeda
Gaucher Disease
4 trials -
Vemlidy
Hospital Authority, Hong Kong
Chronic Hepatitis b
1 trial -
Vemurafenib
Hoffmann-La Roche
Neoplasms
1 trial -
Venetoclax
AbbVie
Acute Myeloid Leukemia (AML)
1 trial -
Video directly observed therapy with contingency management
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Vifor
The First People's Hospital of Lianyungang
Malnutrition
1 trial -
Vitamin D3
Hospital Authority, Hong Kong
Bronchiectasis
1 trial -
Vitamine E-400 complex, Microgynon 30, 0,15 mg/0,03 mg omhulde tabletten
Disc Medicine
Migraine
1 trial -
Voltaren SPORT, 11,6 mg/g, żel, Voltaren MAX, 23,2 mg/g, żel
HALEON AUSTRALIA PTY LTD
Mild/non-serious osteoarthritis (OA) of the knee.
1 trial -
Vonoprazan
Takeda
Reflux Esophagitis
1 trial -
Vonoprazan
The First People's Hospital of Lianyungang
Ulcers, Gastric
1 trial -
Vonoprazan
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
2 trials -
Vonoprazan
Takeda
Erosive Esophagitis
3 trials -
Vonoprazan and Amoxicillin for the first 7 days
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
Vortioxetine
Takeda
Type2 Diabetes
1 trial -
Vortioxetine
Takeda
Depressive Disorder
1 trial -
Vortioxetine
Takeda
Healthy Volunteers
1 trial -
Vortioxetine
Takeda
Schizophrenia
1 trial -
Vortioxetine
Takeda
Unipolar Major Depression
1 trial -
Vortioxetine 10 mg
Takeda
Age-related Cognitive Decline
1 trial -
Vyndaqel 61 mg soft capsules
Monte Rosa Therapeutics
Transthyretin cardiac amyloidosis
1 trial -
Vyvanse (lisdexamfetamine dimesylate)
Takeda
Attention Deficit Hyperactivity Disorder (ADHD)
1 trial -
Vyvgart 20 mg/mL concentrate for solution for infusion
The George Institute
Patients affected by generalized myasthenia gravis
1 trial -
WARFARIN, LYSINE ASPIRIN, CLOPIDOGREL, ACETYLSALICYLIC ACID, ATORVASTATIN, DILTIAZEM, BISOPROLOL, ACETYLCHOLINE CHLORIDE, GLYCERYL TRINITRATE, RAMIPRIL
Fondazione Telethon ETS
Myocardial infarction with non-obstructive coronary arteries (MINOCA)
1 trial -
Wangbi granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rheumatoid Arthritis
1 trial -
Warfarin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Anticoagulation
1 trial -
Web-based smoking cessation program
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking
1 trial -
Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen
NovoThirteen
Obesity
1 trial -
Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen
Lacuna Pharma Pty Ltd
Adipositas
1 trial -
Wegovy 2.4 mg solution for injection in pre-filled pen
The George Institute
obstructive sleep apnea
1 trial -
Wen Xin granule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial
Frequently asked questions
How many Approved programs pipeline programs are in the directory?
1,839 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources · All pipeline programs